NXTC
Price
$0.45
Change
-$0.01 (-2.17%)
Updated
Jun 27 closing price
Capitalization
12.62M
31 days until earnings call
PMVP
Price
$1.07
Change
-$0.01 (-0.93%)
Updated
Jun 27 closing price
Capitalization
55.59M
39 days until earnings call
Interact to see
Advertisement

NXTC vs PMVP

Header iconNXTC vs PMVP Comparison
Open Charts NXTC vs PMVPBanner chart's image
NextCure
Price$0.45
Change-$0.01 (-2.17%)
Volume$175.86K
Capitalization12.62M
PMV Pharmaceuticals
Price$1.07
Change-$0.01 (-0.93%)
Volume$103.79K
Capitalization55.59M
NXTC vs PMVP Comparison Chart in %
Loading...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NXTC vs. PMVP commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NXTC is a Buy and PMVP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (NXTC: $0.46 vs. PMVP: $1.07)
Brand notoriety: NXTC and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NXTC: 74% vs. PMVP: 43%
Market capitalization -- NXTC: $12.62M vs. PMVP: $55.59M
NXTC [@Biotechnology] is valued at $12.62M. PMVP’s [@Biotechnology] market capitalization is $55.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NXTC’s FA Score shows that 1 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • NXTC’s FA Score: 1 green, 4 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, PMVP is a better buy in the long-term than NXTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NXTC’s TA Score shows that 3 TA indicator(s) are bullish while PMVP’s TA Score has 4 bullish TA indicator(s).

  • NXTC’s TA Score: 3 bullish, 6 bearish.
  • PMVP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PMVP is a better buy in the short-term than NXTC.

Price Growth

NXTC (@Biotechnology) experienced а -2.72% price change this week, while PMVP (@Biotechnology) price change was -1.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

NXTC is expected to report earnings on Jul 31, 2025.

PMVP is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PMVP($55.6M) has a higher market cap than NXTC($12.6M). PMVP YTD gains are higher at: -29.139 vs. NXTC (-40.700). NXTC has higher annual earnings (EBITDA): -50.34M vs. PMVP (-87.97M). PMVP has more cash in the bank: 160M vs. NXTC (55.9M). PMVP has less debt than NXTC: PMVP (1.11M) vs NXTC (4.91M). NXTC (0) and PMVP (0) have equivalent revenues.
NXTCPMVPNXTC / PMVP
Capitalization12.6M55.6M23%
EBITDA-50.34M-87.97M57%
Gain YTD-40.700-29.139140%
P/E RatioN/AN/A-
Revenue00-
Total Cash55.9M160M35%
Total Debt4.91M1.11M444%
FUNDAMENTALS RATINGS
NXTC: Fundamental Ratings
NXTC
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NXTCPMVP
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCII91.951.44
+1.59%
LCI Industries
WBD11.300.15
+1.35%
Warner Bros Discovery
SPTN26.510.11
+0.42%
SpartanNash Company
ASMB17.31N/A
N/A
Assembly Biosciences
OTRK0.97N/A
N/A
Ontrak Inc

NXTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with SRPT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
-0.61%
SRPT - NXTC
38%
Loosely correlated
-0.70%
ACET - NXTC
35%
Loosely correlated
-6.71%
VXRT - NXTC
27%
Poorly correlated
-7.14%
PMVP - NXTC
27%
Poorly correlated
-0.93%
MBIO - NXTC
27%
Poorly correlated
-0.97%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
-0.93%
CLLS - PMVP
39%
Loosely correlated
-2.54%
XNCR - PMVP
38%
Loosely correlated
-3.10%
ACIU - PMVP
37%
Loosely correlated
-2.90%
COGT - PMVP
36%
Loosely correlated
-3.14%
ABCL - PMVP
36%
Loosely correlated
-3.48%
More